Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOvid Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.17 | -$0.14 | -$0.16 |
| Q2 2025 | 2 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2025 | 2 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2025 | 2 | -$0.17 | -$0.17 | -$0.17 |
| Q1 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q2 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q4 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
Ovid Therapeutics Inc. Earnings Date And Information
Ovid Therapeutics Inc. last posted its earnings results on Tuesday, March 11th, 2025. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.16 by $0.03. The company had revenue of 76,000 for the quarter and had revenue of 566,000 for the year. Ovid Therapeutics Inc. has generated $0 earnings per share over the last year ($-0.37 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. Ovid Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Ovid Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/11/2025 | Q4 2024 | -$0.16 | $0.00 | N/A | N/A | $76,000 |
| 11/12/2024 | Q3 2024 | -$0.19 | -$0.20 | -0.01 | $105,500 | $173,000 |
| 08/13/2024 | Q2 2024 | -$0.22 | $0.12 | 0.34 | $65,375 | $169,000 |
| 05/14/2024 | Q1 2024 | -$0.23 | -$0.17 | 0.06 | N/A | $148,000 |
| 03/08/2024 | Q4 2023 | -$0.17 | -$0.22 | -0.05 | N/A | $141,562 |
| 11/03/2023 | Q3 2023 | -$0.18 | -$0.16 | 0.02 | $45,833 | $108,972 |
| 08/04/2023 | Q2 2023 | -$0.21 | -$0.18 | 0.03 | $47,750 | $75,000 |
| 05/05/2023 | Q1 2023 | -$0.18 | $21.60 | 21.78 | N/A | $66,160 |
| 03/13/2023 | Q4 2022 | -$0.19 | -$0.16 | 0.03 | N/A | $46,280 |
| 11/08/2022 | Q3 2022 | -$0.21 | -$0.16 | 0.05 | N/A | $11,102 |
| 08/09/2022 | Q2 2022 | -$0.23 | -$0.21 | 0.02 | N/A | $0 |
| 05/10/2022 | Q1 2022 | $1.17 | -$0.23 | -1.4 | N/A | $1.45 M |
| 03/15/2022 | Q4 2021 | -$0.17 | -$0.39 | -0.22 | N/A | $-416,348,792 |
| 11/10/2021 | Q3 2021 | -$0.19 | -$0.17 | 0.02 | N/A | $0 |
| 08/13/2021 | Q2 2021 | -$0.15 | -$0.23 | -0.08 | N/A | $0 |
| 05/13/2021 | Q1 2021 | $1.68 | $2.55 | 0.87 | N/A | $208.38 M |
| 03/15/2021 | Q4 2020 | -$0.31 | -$0.35 | -0.04 | N/A | $5.70 M |
| 11/12/2020 | Q3 2020 | N/A | -$0.28 | N/A | $100,000 | $6.91 M |
| 08/10/2020 | Q2 2020 | -$0.38 | -$0.41 | -0.03 | N/A | $0 |
| 05/07/2020 | Q1 2020 | -$0.34 | -$0.37 | -0.03 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ovid Therapeutics Inc. Earnings: FAQ's
Ovid Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based offlast year's report dates.
In the previous quarter, Ovid Therapeutics Inc. (:OVID) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.16 by $0.03.
The conference call for Ovid Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Ovid Therapeutics Inc.'s latest earnings report can be read online.
Ovid Therapeutics Inc. (:OVID) has a recorded annual revenue of $566,000.
Ovid Therapeutics Inc. (:OVID) has a recorded net income of $-26,433,000.Ovid Therapeutics Inc. has generated $-0.37 earnings per share over the last four quarters.
Ovid Therapeutics Inc. (:OVID) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is -0.03.